# Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

> **NCT00387023** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 12 (actual)

## Conditions studied

- Non-Hodgkin's Lymphoma
- Lymphoma

## Interventions

- **DRUG:** Rituximab
- **DRUG:** Zevalin

## Key facts

- **NCT ID:** NCT00387023
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2013-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00387023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00387023, "Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00387023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*